KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Opko Health (OPK) Cash from Operations (2016 - 2025)

Historic Cash from Operations for Opko Health (OPK) over the last 16 years, with Q3 2025 value amounting to -$34.6 million.

  • Opko Health's Cash from Operations rose 5505.0% to -$34.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$197.0 million, marking a year-over-year decrease of 1108.17%. This contributed to the annual value of -$183.5 million for FY2024, which is 55073.94% down from last year.
  • Per Opko Health's latest filing, its Cash from Operations stood at -$34.6 million for Q3 2025, which was up 5505.0% from -$83.4 million recorded in Q2 2025.
  • Over the past 5 years, Opko Health's Cash from Operations peaked at $33.4 million during Q3 2021, and registered a low of -$83.4 million during Q2 2025.
  • In the last 5 years, Opko Health's Cash from Operations had a median value of -$26.4 million in 2024 and averaged -$22.2 million.
  • As far as peak fluctuations go, Opko Health's Cash from Operations surged by 20270.82% in 2023, and later crashed by 714246.58% in 2024.
  • Over the past 5 years, Opko Health's Cash from Operations (Quarter) stood at -$5.6 million in 2021, then tumbled by 460.34% to -$31.6 million in 2022, then decreased by 21.11% to -$38.3 million in 2023, then fell by 15.97% to -$44.4 million in 2024, then rose by 21.98% to -$34.6 million in 2025.
  • Its Cash from Operations stands at -$34.6 million for Q3 2025, versus -$83.4 million for Q2 2025 and -$34.6 million for Q1 2025.